The Danish drugmaker has announced the recommended pricing for its Wegovy tablet that is expected to go on sale in Australia by the end of the year.
The first pill version of GLP-1 weight-loss drugs to be sold in Australia will cost between $260 and $395 per month depending on the dosage, a similar price to the monthly injections currently available.
Danish drugmaker Novo Nordisk on Friday announced the recommended pricing for its Wegovy tablet that is expected to go on sale in Australia by the end of the year.
Gift articles to anyone you choose each month when you subscribe.
Compare how 3 other independent news outlets reported on this story.
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.
Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to a surge in demand for the sought-after peptide which could hit the market by the end of this year.
